Lidocain/Prilocain Idd

Lidocaine and Prilocaine, the active ingredients in Lidocain/Prilocain Idd, are local anesthetics presented as a topical formulation for transdermal use. They provide surface anesthesia for minor skin procedures and relieve pain from superficial wounds or burns in adults. GNH USA supplies Lidocain/Prilocain Idd as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lidocaine/Prilocaine is a topical local anesthetic used to numb the skin and reduce pain in superficial conditions. - Minor skin procedures: provides rapid, reversible anesthesia for procedures such as biopsies or laser treatment. - Superficial wounds: reduces pain associated with cuts, abrasions, or first‑degree burns. - Dermatologic treatments: facilitates painless removal of skin lesions or application of topical therapies.

Common Side Effects: - Skin irritation or redness at the application site. - Itching or mild burning sensation. - Localized swelling or edema. - Dryness or flaking of the skin. - Mild headache. - Transient numbness extending beyond the treated area.

Serious or Rare Side Effects: - Allergic reactions such as urticaria, angioedema, or anaphylaxis. - Methemoglobinemia, especially with extensive use. - Systemic toxicity presenting as dizziness, tinnitus, or seizures. - Severe dermatitis or contact eczema. - Cardiovascular disturbances like hypotension or arrhythmia. - Respiratory depression in cases of overdose.

Before using Lidocain/Prilocain Idd, consider the following precautions: - Allergy assessment: avoid if the patient has known hypersensitivity to amide‑type local anesthetics. - Skin integrity: apply only to intact, non‑infected skin; do not use on open wounds or mucous membranes. - Application area: limit the total surface area to the amount recommended by the prescriber to prevent systemic absorption. - Patient populations: use with caution in infants, the elderly, or patients with hepatic impairment. - Drug interactions: review concomitant medications that may increase risk of methemoglobinemia or CNS effects. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Lidocain/Prilocain Idd may interact with other substances that affect its safety profile. Major Interactions (Avoid): - Concurrent use with other local anesthetics: risk of cumulative toxicity. - Co‑administration with methemoglobin‑inducing agents (e.g., benzocaine): may increase methemoglobinemia risk. - Use with systemic central nervous system depressants: potential potentiation of CNS depression. Moderate Interactions (Monitor Closely): - CYP2C9 inhibitors (e.g., fluconazole): may reduce lidocaine metabolism. - Drugs that lower seizure threshold (e.g., tramadol): may increase seizure risk. - Anticoagulants: may enhance bleeding risk if invasive procedures are performed after application.